Vanguard Health Care Fund

Vanguard Health Care Fund

Last Update: 01-31-2017

Number of Stocks: 75
Number of New Stocks: 5

Total Value: $41,768 Mil
Q/Q Turnover: 4%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Vanguard Health Care Fund' s Profile & Performance

Profile

Edward Owens has worked in investment management for over 30 years. He has managed the Vanguard Health Care Fund (VGHCX) since its inception in May 1984. Owens received a B.A. from the University of Virginia, and an M.B.A from Harvard Business School.

Web Page:https://personal.vanguard.com/us/funds/snapshot?FundId=0052&FundIntExt=INT

Investing Philosophy

Mr. Owens invests primarily in health care companies. His strategy is characterized by a long-term focus and careful attention to valuations.

Historical Allocation of Stock, Bonds, Cash

Total Holding History

Performance of Vanguard Healthcare Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
2016011.96-12.0
201512.651.3811.3
201428.5213.6914.8
3-Year Cumulative44.8 (13.1%/year)29 (8.9%/year)15.8 (4.2%/year)
201343.1932.3910.8
201215.1116-0.9
5-Year Cumulative138.6 (19%/year)98.2 (14.7%/year)40.4 (4.3%/year)
201111.452.119.3
20106.1615.06-8.9
200920.9626.46-5.5
2008-18.45-3718.5
20074.425.49-1.1
10-Year Cumulative190.8 (11.3%/year)95.7 (6.9%/year)95.1 (4.4%/year)
200610.8715.79-4.9
200515.414.9110.5
20049.5110.88-1.4
200326.5828.68-2.1
2002-11.36-22.110.7
15-Year Cumulative357.2 (10.7%/year)164.2 (6.7%/year)193 (4%/year)
2001-6.87-11.895.0
200060.53-9.169.6
19997.0521.04-14.0
199840.828.5812.2
199728.5733.36-4.8
20-Year Cumulative1224.6 (13.8%/year)339.2 (7.7%/year)885.4 (6.1%/year)
199621.3622.96-1.6
199545.1737.587.6
19949.541.328.2
199311.8110.081.7
1992-1.577.62-9.2
25-Year Cumulative2713.4 (14.3%/year)791.8 (9.1%/year)1921.6 (5.2%/year)
199146.3230.4715.9
199016.79-3.119.9
198932.9531.691.3
198828.4116.6111.8
1987-0.55.1-5.6
30-Year Cumulative8066.8 (15.8%/year)1719.7 (10.2%/year)6347.1 (5.6%/year)
198621.4218.62.8
198545.7631.614.2

Top Ranked Articles

Walgreens, Rite Aid Reduce Price, Postpone Closing of Merger Deal’s value reduced by at least $2 billion
Walgreens Boots Alliance (NASDAQ:WBA) and Rite Aid Corp. (NYSE:RAD) announced on Monday they are reducing the price and postponing the close of their definitive merger agreement. Read more...
Market-Beating Vanguard Health Care Fund Adds Shares to 5 Positions Solid growth has attended the sector until this year
Against a backdrop of solid growth for the sector, the outperforming Vanguard Health Care Fund (Trades, Portfolio) replenished its portfolio in the first quarter with increases in 27 holdings and reductions or removal of 28 holdings. Read more...
Edward Owens Top 2nd Quarter Investments Hologic, Biogen, Illumina among his top investments
Edward Owens has managed the Vanguard Health Care Fund (Trades, Portfolio) (VGHCX) since its inception in May 1984. During the second quarter of 2016, the fund increased several stakes. The following are the ones with the highest performance since that buy. Read more...
John Paulson Sells Allergan, Precision Castparts, AIG Top sales by the investor during the 4th quarter
John Paulson (Trades, Portfolio) is the president and portfolio manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the third-largest hedge fund in the world managing approximately $29 billion in merger, event and distressed strategies. The following are the guru's largest sales during the fourth quarter of 2015. Read more...
Vanguard Health Care Fund Sells Amgen, Baxter The guru's largest 3rd-quarter sales
Following its third-quarter report, Vanguard Health Care Fund (Trades, Portfolio) holds 73 stocks with a total value of $46.245 billion. The following are the sales with the largest impacts on its portfolio. Read more...
» More Vanguard Health Care Fund Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

FDA Approves Abbott Labs' Devices for MRI Scans Patients with Assurity MRI pacemaker or Tendril MRI pacing lead can have full-body scans Vanguard Health Care Fund,Ken Fisher - FDA Approves Abbott Labs' Devices For MRI Scans
Good news for heart patients implanted with Abbott Labs’ (NYSE:ABT) Assurity MRI pacemaker and Tendril MRI pacing lead. The U.S. Food and Drug Administration (FDA) has approved the two devices for total-body MRI scans. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Vanguard Health Care Fund Gains 5 New Stocks 2 of the fund’s new holdings recently went public Vanguard Health Care Fund,Jim Simons,Murray Stahl - Vanguard Health Care Fund Gains 5 New Stocks
The Vanguard Health Care Fund (Trades, Portfolio) established five new holdings in the final quarter of 2016. The holdings are ConvaTec Group PLC (LSE:CTEC), Ionis Pharmaceuticals Inc. (NASDAQ:IONS), Samsung BioLogics Co. Ltd. (XKRX:207940), Shanghai Fosun Pharmaceutical Group Co. Ltd. (SHSE:600196) and Aspen Pharmacare Holdings Ltd. (JSE:APN). More...

VANGUARD, HEALTHCARE, BUYS, 4Q


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Walgreens, Rite Aid Reduce Price, Postpone Closing of Merger Deal’s value reduced by at least $2 billion Vanguard Health Care Fund,David Einhorn - Walgreens, Rite Aid Reduce Price, Postpone Closing Of Merger
Walgreens Boots Alliance (NASDAQ:WBA) and Rite Aid Corp. (NYSE:RAD) announced on Monday they are reducing the price and postponing the close of their definitive merger agreement. More...

WALGREENS, RITE AID, MERGER


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Manning & Napier’s Top 3 New Holdings Firm invested in wide array of industries in the 4th quarter Manning & Napier Advisors Inc.,Vanguard Health Car - Manning & Napier’s Top 3 New Holdings
Manning & Napier Advisors Inc. acquired 35 new holdings during the final quarter of 2016. The firm’s top three new holdings are Bristol-Myers Squibb Co. (NYSE:BMY), Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Campbell Soup Co. (NYSE:CPB). More...

MANNING, NAPIER, BUYS, 4Q, 2016


  • Currently 3.67/5

Rating: 3.7/5 (3 votes)

A Growth Stock in the Land of Value Stocks? A company with excellent earnings power has pulled back recently, but its debt level may rule it out for value investors PRIMECAP Management,Vanguard Health Care Fund,Larr - A Growth Stock In The Land Of Value Stocks?
Over the past two weeks, the price of Thermo Fisher Scientific Inc. (NYSE:TMO) shares has dropped nearly $20, landing it on the Undervalued Predictable screener list at GuruFocus. More...

UNDERVALUED, PREDICTABLE, DIAGNOSTICS & RESEARCH, LABORATORY EQUIPMENT, GROWTH STOCKS, LONG


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Can Universal Health Services Power Past the Political Turbulence? Expect lots of volatility for the company in the near term, but what is the outlook for the longer term? Lee Ainslie,Vanguard Health Care Fund,Andreas Halv - Can Universal Health Services Power Past The Political Turbulence?
A small earthquake shook the health care industry on the morning of Nov. 9 when it became clear a new administration would take charge, an administration that promised a major overhaul of the system. More...

HEALTHCARE, HEALTH CARE, ACUTE CARE, BEHAVIORAL HEALTH, UNIVERSAL HEALTH, DONALD TRUMP, AFFORDABLE CARE ACT,


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ken Fisher Continues to Buy Allergan, HP, Lowe's Stocks the guru bought during the 2nd and 3rd quarters Ken Fisher,Vanguard Health Care Fund,John Paulson, - Ken Fisher Continues To Buy Allergan, HP, Lowe's
Ken Fisher (Trades, Portfolio) is the CEO and chief investment officer of Fisher Investments. The investment philosophy at Fisher Investments is based on the idea that supply and demand of securities is the sole determinant of their prices. In both the second and third quarters the guru bought shares in the following stocks: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Paul Tudor Jones Exits EMC, Boosts Facebook, PepsiCo, Biogen The guru's most important trades of the 3rd quarter Paul Tudor Jones,Vanguard Health Care Fund,Barrow  - Paul Tudor Jones Exits EMC, Boosts Facebook, PepsiCo, Biogen
Paul Tudor Jones (Trades, Portfolio) is the president and founder of Tudor Investment Corp. and was featured in Jack D. Schwager's classic "Market Wizards." During the third quarter the guru’s most important trades were the following: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Vanguard Health Care Fund Sells Amgen, Baxter The guru's largest 3rd-quarter sales Vanguard Health Care Fund,PRIMECAP Management,Jim  - Vanguard Health Care Fund Sells Amgen, Baxter
Following its third-quarter report, Vanguard Health Care Fund (Trades, Portfolio) holds 73 stocks with a total value of $46.245 billion. The following are the sales with the largest impacts on its portfolio. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Merck Announces 3rd Quarter Results Company reported sales growth, progress with new products Vanguard Health Care Fund - Merck Announces 3rd Quarter Results
Merck & Co. Inc. (NYSE:MRK) released its third quarter report and raised its full-year outlook on Tuesday. More...

HEALTHCARE, MERCK, THIRD QUARTER, 3Q, REPORT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Michael Price Trims Boston Scientific, Buys Outerwall The guru's largest trades of 2nd quarter Michael Price,Vanguard Health Care Fund,PRIMECAP M - Michael Price Trims Boston Scientific, Buys Outerwall
Michael Price (Trades, Portfolio) is the 271st richest person in the world, according to Forbes. A renowned money manager, he learned finance as a $200-a-week research assistant under Max Heine. The following are his largest trades of the second quarter: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Carl Icahn Buys Allergan Pharmaceutical company is new holding Carl Icahn,Vanguard Health Care Fund,Daniel Loeb,J - Carl Icahn Buys Allergan
During the second quarter, Carl Icahn (Trades, Portfolio) of Icahn Capital Management acquired a new holding in Allergan PLC (NYSE:AGN). More...

ICAHN, ALLERGAN, BUY


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Jean Hynes Adds to Chugai Pharmaceutical Stake Company has reputation for developing drugs that 'benefit the world' Vanguard Health Care Fund - Jean Hynes Adds To Chugai Pharmaceutical Stake
Jean Hynes of the Vanguard Health Care Fund (Trades, Portfolio) added 320,542 shares of Chugai Pharmaceutical (TSE:4519) at an average price of 3,658.41 Japanese yen ($36.51) during the second quarter. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Vanguard Adds to Eisai Stake Company has 75 years of operating experience, strong financial statements and a broad product portfolio Vanguard Health Care Fund - Vanguard Adds To Eisai Stake
Jean Hynes of the Vanguard Health Care Fund (Trades, Portfolio) added 1,094,126 shares to the stake in Eisai (TSE:4523) during the second quarter. The trade had a 0.13% impact on the portfolio. Vanguard now owns 14,033,001 shares in the company. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Vanguard Health Care Fund Adds to Stake in UCB UCB is expanding its operations and the dividend yield is close to a 2-year high Vanguard Health Care Fund - Vanguard Health Care Fund Adds To Stake In UCB
Jean Hynes of the Vanguard Health Care Fund added to her stake in UCB (XBRU:UCB) during the second quarter at an average price of €66.98 euros ($74.26) per share. The trade had a 0.1% impact on Hynes portfolio. She now owns 11,342,503 shares of the company. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Jean Hynes Reduces Stake in Actelion Actelion reached its 10-year high during second quarter Vanguard Health Care Fund - Jean Hynes Reduces Stake In Actelion
During the second quarter, guru Jean Hynes reduced her stake in Actelion (XSWX:ATLN) at an average price of 155.36 Swiss francs ($160). The trade had a 0.13% impact on Hynes' portfolio. She now owns 2,233,722 shares of the company. More...

VANGUARD, INVESTING, FUND


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Edward Owens Top 2nd Quarter Investments Hologic, Biogen, Illumina among his top investments Vanguard Health Care Fund - Edward Owens Top 2nd Quarter Investments
Edward Owens has managed the Vanguard Health Care Fund (Trades, Portfolio) (VGHCX) since its inception in May 1984. During the second quarter of 2016, the fund increased several stakes. The following are the ones with the highest performance since that buy. More...

INVESTING, GURU, OWENS


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Vanguard Sold Shares in 7 of Top 10 Quarterly Transactions Guru exited position in Pfizer in 2nd quarter Vanguard Health Care Fund - Vanguard Sold Shares In 7 Of Top 10 Quarterly Transactions
Seven of Vanguard Health Care Fund (Trades, Portfolio)’s top 10 second-quarter transactions were divestitures or reductions, including its most noteworthy deal of the quarter. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ruane Cunniff Buys JD.Com, Yelp, LinkedIn Investor's largest buys of the 1st quarter Ruane Cunniff,Vanguard Health Care Fund,Meridian F - Ruane Cunniff Buys JD.Com, Yelp, LinkedIn
Ruane Cunniff (Trades, Portfolio) is a value investor focused on the intrinsic value of a business. The firm is a long-term investor and will buy stocks and hold them for quite awhile, even if sometimes the stocks seem to be overvalued. During the first quarter the investor bought shares in the following stocks. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Steve Mandel Buys Allergan, Baxalta, PayPal The guru's top buys in the 1st quarter Steve Mandel,Vanguard Health Care Fund,John Paulso - Steve Mandel Buys Allergan, Baxalta, PayPal
Steve Mandel (Trades, Portfolio), the founder of Lone Pine Capital, a long/short equity money manager, bought shares in the following stocks in the first quarter. More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK